Pharma & Biotech @ Astbury - your gateway to innovation

Find Out More


A new paper marks a step forward in our understanding of peptide fragments and methods for simulating them. Researchers from Leeds have, for the first time, calculated the solubility diagram of amyloid β (16-22) peptide – a peptide fragment related to the onset of Alzheimer's disease. more >
A new platform for photoinduced-crosslinking could transform protein research. Leading academics at the Astbury Centre for Structural Molecular Biology have significantly advanced a method for studying the interactions of proteins, which they say should transform research in this area. more >
UK scientists have found a new way to identify people with the most aggressive types of lymphoma, which are less likely to respond to standard drugs. more >


Despite huge investment and changes in practices over the years, the rate of drug discovery has not increased and the cost of bringing effective drugs to market remains very high.

Pharmaceutical and Biotechnology innovation at the Astbury Centre for Structural Molecular Biology brings together expertise in a range of physical and biological sciences to pioneer innovative approaches to drug discovery. We work with pharmaceutical and biotechnology companies, as well as supporting industries, to help the sector discover safe new medicines faster.

The scale of the University’s activities and state of the art facilities enable us to operate in a wide variety of areas, through exploitation of outstanding research expertise and engagement with industry. By identifying how our expertise can meet industry needs, we are able to address some of the real problems that slow the progress of getting new drugs to market.

Please contact us for further information or to discuss how we may be able to support your company in providing solutions to your current and future challenges in pharmaceutical development and drug discovery.